首页 > 市场调查报告书 > 医疗设备

体外诊断生技设备

到 2030 年北美分子诊断市场预测 - 区域分析 - 按疾病领域、技术、产品和服务以及最终用户

市场调查报告书

商品编码

1452578

到 2030 年北美分子诊断市场预测 - 区域分析 - 按疾病领域、技术、产品和服务以及最终用户

North America Molecular Diagnostics Market Forecast to 2030 - Regional Analysis - by Disease Area, Technology, Product and Services, and End User

出版日期: 2024年01月05日 | 出版商:

The Insight Partners | 英文 125 Pages | 订单完成后即时交付

价格

简介目录图表

北美分子诊断市场预计将从2022年的80.5648亿美元成长到2030年的207.4038亿美元。预计2022年至2030年CAGR为12.5%。

新产品的开发和即时检测需求的增加推动了北美分子诊断市场

即时检测是医学的一个分支，其分析范围和临床应用不断发展。即时检测解决方案提供者提供各种评估的产品，从血糖测量到黏弹性凝血测定。这些测试消除了运输和製备临床样本的时间，使专业人员能够在更短的时间内做出额外测试或治疗的临床决策。这种新兴的医疗保健解决方案正在被患者和医疗保健服务提供者积极采用。即时检测广泛用于治疗、诊断和患者监测等应用。此外，即时照护产品和服务可协助医疗保健提供者满足病患对居家医疗照护的需求。事实证明，这些产品和服务在 COVID-19 大流行期间特别有用，它们允许患者在家中接受检测，而不是前往诊断或治疗机构，从而降低感染风险。因此，对现场检测的需求不断增长有利于分子诊断市场。

北美分子诊断市场概况

北美分子诊断市场已细分为美国、加拿大和墨西哥。技术先进产品的日益采用、研发活动的增加、大型医疗保健企业的存在以及分子诊断的使用不断增加是推动该地区分子诊断市场成长的关键因素。 2022年，美国占据北美分子诊断市场最大份额。

北美分子诊断市场收入及 2030 年预测（百万美元）

北美分子诊断市场细分

北美分子诊断市场分为疾病领域、技术、产品和服务、最终用户和国家。

根据疾病领域，北美分子诊断市场分为传染病、肿瘤、基因检测、心臟病、免疫系统疾病等。 2022 年，传染病细分市场占据北美分子诊断市场份额最大的份额。

根据技术，北美分子诊断市场分为聚合酶炼式反应（PCR）、原位杂交、等温核酸扩增技术（INAAT）、DNA定序和下一代定序（NGS）、DNA微阵列等。聚合酶炼式反应 (PCR) 领域在 2022 年占据了北美最大的分子诊断市场份额。聚合酶炼式反应 (PCR) 进一步细分为 RT-PCR、qPCR、多重 PCR 等。

根据产品和服务，北美分子诊断市场分为检测和试剂盒、仪器、服务和软体。 2022 年，检测和试剂盒领域占据了北美最大的分子诊断市场。

根据最终用户，北美分子诊断市场分为诊断实验室、医院和诊所、研究和学术机构等。 2022 年，诊断实验室领域占据北美最大的分子诊断市场。

依国家划分，北美分子诊断市场分为美国、加拿大和墨西哥。 2022年，美国将主导北美分子诊断市场。

Abbott Laboratories、Agilent Technologies Inc、Thermo Fisher Scientific Inc、F. Hoffmann-La Roche Ltd、Qiagen NV、bioMerieux SA、Illumina Inc、Danaher、Siemens Healthineers AG、Novartis AG 和TBG Diagnostics Limited 是在这些领域运营的一些领先公司。北美分子诊断市场。

Point-of-care testing is a branch of medicine with a rapidly evolving analytical scope and clinical application. Point-of-care testing solution providers offer products for various evaluations, ranging from blood glucose measurement to viscoelastic coagulation assays. Eliminating the time of transportation and preparation of clinical samples, these tests enable professionals to make clinical decisions about additional testing or therapy in less time. This emerging healthcare solution is being aggressively adopted by patients and healthcare service providers. Point-of-care assays are extensively used in therapeutics, diagnostics, and patient monitoring applications, among others. Moreover, point-of-care products and services help healthcare providers in meeting patients' demand for at-home medical care. These products and services proved specifically helpful during the COVID-19 pandemic by allowing patients to take tests from their homes instead of traveling to diagnostic or treatment facilities, thereby lowering the risk of infection. Thus, the rising demand for point-of-care testing benefits the molecular diagnostics market.

North America Molecular Diagnostics Market Overview

The North America molecular diagnostics market has been segmented into the US, Canada, and Mexico. The increasing adoption of technologically advanced products, rise in research & development activities, presence of large healthcare businesses, and growing use of molecular diagnostics are among the key factors propelling the growth of the molecular diagnostics market in this region. The US held the largest share of the North America molecular diagnostics market in 2022.

North America Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Million)

North America Molecular Diagnostics Market Segmentation

The North America molecular diagnostics market is segmented into disease area, technology, product and services, end user, and country.

Based on disease area, the North America molecular diagnostics market is segmented into infectious disease, oncology, genetic testing, cardiac diseases, immune system disorders, and others. The infectious disease segment registered the largest North America molecular diagnostics market share in 2022.

Based on technology, the North America molecular diagnostics market is segmented into polymerase chain reaction (PCR), in situ hybridization, isothermal nucleic acid amplification technology (INAAT), DNA sequencing and next-generation sequencing (NGS), DNA microarrays, and others. The polymerase chain reaction (PCR) segment registered the largest North America molecular diagnostics market share in 2022. The polymerase chain reaction (PCR) is further subsegmented into RT-PCR, qPCR, multiplex PCR, and others.

Based on product and services, the North America molecular diagnostics market is segmented into assays and kits, instruments, and services and software. The assays and kits segment registered the largest North America molecular diagnostics market share in 2022.

Based on end users, the North America molecular diagnostics market is segmented into diagnostic laboratories, hospitals and clinics, research and academic institutes, and others. The diagnostic laboratories segment held the largest North America molecular diagnostics market share in 2022.

Based on country, the North America molecular diagnostics market has been categorized into the US, Canada, and Mexico. The US dominated the North America molecular diagnostics market in 2022.

Abbott Laboratories, Agilent Technologies Inc, Thermo Fisher Scientific Inc, F. Hoffmann-La Roche Ltd, Qiagen NV, bioMerieux SA, Illumina Inc, Danaher, Siemens Healthineers AG, Novartis AG, and TBG Diagnostics Limited are some of the leading companies operating in the North America molecular diagnostics market.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. North America Molecular Diagnostics Market Landscape

4.1 Overview
4.2 PEST Analysis
- 4.2.1 North America PEST Analysis

5. North America Molecular Diagnostics Market - Key Industry Dynamics

5.1 Key Market Drivers:
- 5.1.1 Development of New Products and Increase in Demand for Point-of-Care Testing
- 5.1.2 Surging Prevalence of Associated Diseases
5.2 Market Restraints
- 5.2.1 Limitations Associated with Molecular Testing
5.3 Market Opportunities
- 5.3.1 Advancements in Molecular Diagnostics Technologies
5.4 Future Trends
- 5.4.1 Molecular Diagnostics in Personalized Medicine
5.5 Impact Analysis:

6. Molecular Diagnostics Market - North America Market Analysis

6.1 North America Molecular Diagnostics Market Revenue (US$ Mn), 2022 - 2030

7. North America Molecular Diagnostics Market - Revenue and Forecast to 2030 - by Disease Area

7.1 Overview
7.2 North America Molecular Diagnostics Market Revenue Share, by Disease Area 2022 & 2030 (%)
7.3 Oncology
- 7.3.1 Overview
- 7.3.2 Oncology: North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Infectious Disease
- 7.4.1 Overview
- 7.4.2 Infectious Disease: North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Genetic Testing
- 7.5.1 Overview
- 7.5.2 Genetic Testing: North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
7.6 Cardiac Diseases
- 7.6.1 Overview
- 7.6.2 Cardiac Diseases: North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
7.7 Immune System Disorders
- 7.7.1 Overview
- 7.7.2 Immune System Disorders: North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
7.8 Others
- 7.8.1 Overview
- 7.8.2 Others: North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

8. North America Molecular Diagnostics Market - Revenue and Forecast to 2030 - by Technology

8.1 Overview
8.2 North America Molecular Diagnostics Market Revenue Share, by Technology 2022 & 2030 (%)
8.3 Polymerase Chain Reaction
- 8.3.1 Overview
- 8.3.2 PCR: North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  - 8.3.2.1 RT-PCR
    - 8.3.2.1.1 Overview
- 8.3.3 RT-PCR: North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  - 8.3.3.1 qPCR
    - 8.3.3.1.1 Overview
- 8.3.4 PCR: North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  - 8.3.4.1 Multiplex PCR
    - 8.3.4.1.1 Overview
- 8.3.5 Multiplex PCR: North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  - 8.3.5.1 Others
    - 8.3.5.1.1 Overview
- 8.3.6 Others: North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Isothermal Nucleic Acid Amplification Technology (INAAT)
- 8.4.1 Overview
- 8.4.2 Isothermal Nucleic Acid Amplification Technology (INAAT): North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
8.5 DNA Sequencing and Next-Generation Sequencing (NGS)
- 8.5.1 Overview
- 8.5.2 DNA Sequencing and Next-Generation Sequencing (NGS): North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
8.6 DNA Microarrays
- 8.6.1 Overview
- 8.6.2 DNA Microarrays: North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
8.7 In-Situ Hybridization (ISH)
- 8.7.1 Overview
- 8.7.2 In-Situ Hybridization (ISH): North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
8.8 Others
- 8.8.1 Overview
- 8.8.2 Others: North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

9. North America Molecular Diagnostics Market - Revenue and Forecast to 2030 - by Product and Services

9.1 Overview
9.2 North America Molecular Diagnostics Market Revenue Share, by Product and Services 2022 & 2030 (%)
9.3 Assays and Kits
- 9.3.1 Overview
- 9.3.2 Assays and Kits: North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Instruments
- 9.4.1 Overview
- 9.4.2 Instruments: North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Services and Software
- 9.5.1 Overview
- 9.5.2 Services and Software: North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

10. North America Molecular Diagnostics Market - Revenue and Forecast to 2030 - by End User

10.1 Overview
10.2 North America Molecular Diagnostics Market Revenue Share, by End User 2022 & 2030 (%)
10.3 Hospitals and Clinics
- 10.3.1 Overview
- 10.3.2 Hospitals and Clinics: North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.4 Diagnostics Laboratories
- 10.4.1 Overview
- 10.4.2 Diagnostics Laboratories: North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.5 Research and Academic Institutes
- 10.5.1 Overview
- 10.5.2 Research and Academic Institutes: North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.6 Others
- 10.6.1 Overview
- 10.6.2 Others: North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

11. North America Molecular Diagnostics Market - Country Analysis

11.1 North America Molecular Diagnostics Market, Revenue and Forecast To 2030
- 11.1.1 Overview
  - 11.1.1.1 North America Molecular Diagnostics Market, by Country
- 11.1.2 US
  - 11.1.2.1 Overview
- 11.1.3 US Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
- 11.1.4 US Molecular Diagnostics Market, by Disease Area
- 11.1.5 US Molecular Diagnostics Market, by Technology
  - 11.1.5.1 US Molecular Diagnostics Market, by Polymerase Chain Reaction (PCR)
- 11.1.6 US Molecular Diagnostics Market, by Product and Services
- 11.1.7 US Molecular Diagnostics Market, by End User
- 11.1.8 Canada
  - 11.1.8.1 Overview
- 11.1.9 Canada Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
- 11.1.10 Canada Molecular Diagnostics Market, by Disease Area
- 11.1.11 Canada Molecular Diagnostics Market, by Technology
  - 11.1.11.1 Canada Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
- 11.1.12 Canada Molecular Diagnostics Market, by Product and Services
- 11.1.13 Canada Molecular Diagnostics Market, by End User
- 11.1.14 Mexico
  - 11.1.14.1 Overview
- 11.1.15 Mexico Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
- 11.1.16 Mexico Molecular Diagnostics Market, by Disease Area
- 11.1.17 Mexico Molecular Diagnostics Market, by Technology
  - 11.1.17.1 Mexico Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
- 11.1.18 Mexico Molecular Diagnostics Market, by Product and Services
- 11.1.19 Mexico Molecular Diagnostics Market, by End User

12. North America Molecular Diagnostics Market Industry Landscape

12.1 Overview
12.2 Growth Strategies Done by the Companies in the Market (%)
12.3 Organic Developments
- 12.3.1 Overview
12.4 Inorganic Developments
- 12.4.1 Overview

13. North America Molecular Diagnostics Market, Key Company Profiles

13.1 Abbott Laboratories
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Agilent Technologies Inc
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Thermo Fisher Scientific Inc
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 F. Hoffmann-La Roche Ltd
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Qiagen NV
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 bioMerieux SA
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Illumina Inc
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Danaher
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Siemens Healthineers AG
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Novartis AG
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
13.11 TBG Diagnostics Limited
- 13.11.1 Key Facts
- 13.11.2 Business Description
- 13.11.3 Products and Services
- 13.11.4 Financial Overview
- 13.11.5 SWOT Analysis
- 13.11.6 Key Developments

14. Appendix

14.1 About Us
14.2 Glossary of Terms

简介目录图表

List Of Tables

Table 1. North America Molecular Diagnostics Market Segmentation
Table 2. US Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - Disease Area
Table 3. US Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Technology
Table 4. US Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
Table 5. US Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Product and Services
Table 6. US Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - End User
Table 7. Canada Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - Disease Area
Table 8. Canada Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Technology
Table 9. Canada Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
Table 10. Canada Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Product and Services
Table 11. Canada Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - End User
Table 12. Mexico Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - Disease Area
Table 13. Mexico Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Technology
Table 14. Mexico Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
Table 15. Mexico Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Product and Services
Table 16. Mexico Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - End User
Table 17. Organic Developments Done By Companies
Table 18. Inorganic Developments Done By Companies
Table 19. Glossary of Terms, Molecular Diagnostics Market

List Of Figures

Figure 1. North America - PEST Analysis
Figure 2. North America Molecular Diagnostics Market - Key Industry Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. North America Molecular Diagnostics Market Revenue (US$ Mn), 2022 - 2030
Figure 5. North America Molecular Diagnostics Market Revenue Share, by Disease Area 2022 & 2030 (%)
Figure 6. Oncology: North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Infectious Disease: North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Genetic Testing: North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Cardiac Diseases: North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Immune System Disorders: North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Others: North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. North America Molecular Diagnostics Market Revenue Share, by Technology 2022 & 2030 (%)
Figure 13. PCR: North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. RT-PCR: North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. qPCR: North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Multiplex PCR: North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Others: North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Isothermal Nucleic Acid Amplification Technology (INAAT): North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. DNA Sequencing and Next-Generation Sequencing (NGS): North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. DNA microarrays: North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. In-Situ Hybridization (ISH): North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Others: North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. North America Molecular Diagnostics Market Revenue Share, by Product and Services 2022 & 2030 (%)
Figure 24. Assays and Kits: North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 25. Instruments: North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 26. Services and Software: North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 27. North America Molecular Diagnostics Market Revenue Share, by End User 2022 & 2030 (%)
Figure 28. Hospitals and Clinics: North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 29. Ambulatory Surgical Centers: North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 30. Research and Academic Institutes: North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 31. Others: North America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 32. Molecular Diagnostics Market, 2022 ($Mn)
Figure 33. North America Molecular Diagnostics Market, By Key Countries, 2022 And 2030 (%)
Figure 34. US Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
Figure 35. Canada Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
Figure 36. Mexico Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
Figure 37. Growth Strategies Done by the Companies in the Market (%)